Meningitec suspension for injection in pre-filled syringe Meningococcal serogroup C oligosaccharide conjugate vaccine (adsorbed). 2. QUALITATIVE AND QUANTITATIVE COMPOSITION To the top of the page One dose (0.5ml) contains: Neisseria meningitidis...
Read more
A DEVASTATED couple were told to “prepare for the worst” after their three-year-old son contracted meningitis C. Little Euan Couttie developed septicaemia, the blood poisoning form of the disease, and heartbroken mum and dad Siobhan, 32, and...
Read more
Context An outbreak of meningococcal disease in Quebec province prompted a mass immunization program. The impact of this campaign on the epidemiology of meningococcal disease has not been studied. Objectives To study the impact of a mass...
Read more
When Ohio University freshman Andrea Robinson felt sick in February, she and her father thought it was the flu. They had heard about several cases of meningitis on campus, but she reminded her father that she was vaccinated against the disease so...
Read more Serogroup C meningococcal conjugate vaccines were introduced in Greece in 2001, and although no cases of serogroup C meningococcal disease were recorded in 2004, a steady increase was observed since 2005. In this study, serum bactericidal...
Read more
Two batches of Meningitis C vaccine which were distributed in January and February of 2009 are being recalled as they were found to contain Staphylococcus aureus, a potientially dangerous bacteria. Hundreds, if not thousands of babies could have...
Read more
Complete article What About Safety Tests? According to the DOH website, www.immunisation.org.uk, ‘”Before any vaccine can be used it has to go through many tests. Research from all over the world shows that vaccines are the safest way of...
Read more
The Truth About MMR Andrew Wakefield, the gastroenterologist who first discovered a link between the MMR vaccine, crohn’s disease and autism, recently went before the General Medical Council (GMC) accused of professional misconduct for daring to...
Read more
Abstract Data from routine surveillance during two mass immunisation campaigns (MIC) with Measles-mumps-rubella (MMR)vaccine using Leningrad-Zagreb mumps strain in two states in Brazil were analysed to estimate the risk of vaccine-related...
Read more
Abstract Measles-mumps-rubella (MMR) vaccines containing the Urabe strain of mumps were withdrawn in the United Kingdom in 1992 following demonstration of an increased risk of aseptic meningitis 15-35 days after vaccination. Following...
Read more Abstract A mass immunization campaign with a Urabe-containing measles-mumps-rubella vaccine was carried out in 1997 in the city of Salvador, northeastern Brazil, with a target population of children aged 1-11 years. There was an outbreak of...
Read more Abstract PIP: The incidence of subacute sclerosing panencephalitis (SSPE), a progressive and fatal neurodegenerative disease caused by the measles virus, has declined with widespread use of measles vaccine. The risk of SSPE after measles...
Read more